OUTPATIENT CLINIC PROFESSIONAL SERVICE: CPT CODE 11980
Indication: For treating patients with various
imbalances of the reproductive endocrine hormone system who have failed to
achieve adequate therapeutic benefit with other, more “conventional” methods of
hormone administration, including oral and transdermal routes. This procedure is reserved, as a last
resort, for patients who have exhausted all other reasonable alternatives for
reproductive endocrine hormone replacement.
REFERENCES
1
Anderson
CHM, Rain SK Forsling ML, et al: Oestrogen replacement after oophorectomy:
comparison of patches and implants. Br Med J 1992;305:90-91.
2
Asch RH, Greenblatt RB,
Mahesh VB: Pure crystalline estradiol pellet implantation for contraception.
Int J Fertil 1978;23:100-105.
3
Barlow DH, Abdalla HI,
Roberts ADG, et al: Long-term hormone implant therapy-hormonal and clinical
effects. Obstet Gynecol 1986;67:321-325.
4
Bennett HG Jr, Biskind
G, Mark J: Subcutaneous implantation of compressed crystalline estradiol pellets in the treatment of
menopausal cases. Am J Obstet Gynecol 1940;39:504.
5
Bewley S, Bewley T:
25mg oestradiol implants - the dosage of first choice for subcutaneous
oestrogen replacement therapy. Br J Obstet Gynaecol 1993;100:397.
6
Bonduelle M, McEwan HP:
Monitoring oestradiol implantation. Lancet: 1987;2:1404-1405.
7
Brincat M, Magos A,
Studd JWW, et al: Subcutaneous hormone implants for the control of climacteric
symptoms. Lancet 1984;1:16-18.
8
Brook JG, Aviram M,
Oettinger M, et al: The effect of oestrogen implants on high density
lipoprotein and its subfractions in women in their premature menopause. Maturitis
1982;4:257-265.
9
Brown ML, Lucentre ER,
Alesbury JM, et al: Treatment of the surgical menopause with estradiol pellets
at the time of operation. Am J Obstet Gynaecol 1951;61:200-201.
10
Bryner JR, Greenblatt
RB, Ellegoode JO, et al: Serum levels of estrone and estradiol after
implantation of estradiol pellets. So Med J 1979;72:711.
11
Burger HG, Hailes J,
Menclaus M, et al: The management of persistent symptoms with
estradiol-testosterone implants: clinical, lipid and hormone results.
Maturitas1984;6:351-358.
12
Campbell s, Whitehead
MI: Potency and hepatocellular effects of oestrogen after oral percutaneous and
subcutaneous administration. In Controversial Climacteric, ed by PA van Keep,
WH Utian, A Vermeneulen. Lancaster, UK MTP Press 1988, pp103-125.
13
Cardozo LD, Gibb DMF,
Studd JWW, et al.: The use of hormone implants for climacteric symptoms. Am J
Obstet Gynecol1984;148:336-337.
14
Cardozo L, Gibb DMF,
Tuck SM, et al: The effects of subcutaneous hormone implants during the
climacteric. Maturitas1984;5:177.
15
Crook D, Montgomery JC,
Godsland IF, et al: Lipid and carbohydrate metabolism in premenopausal women
given subdermal estradiol implants. Horm Metab Res1991;23:174.
16
Davis SR, McCloud B,
Strauss BJG, et al.: Testosterone enhances estradiol effects on postmenopausal
bone density and sexuality. Maturitas1995;21:227.
17
Deansley R, Parkes AS:
Further experiments on administration of hormones by subcutaneous implantation
of tablets. Lancet1939;2:606-608.
18
Delaplaine RW, Bottomy
JR, Blatt M, et al: Effective control of surgical menopause by estradiol pellet
implantation at the time of surgery. Surg Gynecol Obstet1952;94:323-333.
19
Emmes CW: Rate of
absorption of androgens and estrogens in free esterified form from
subcutaneously implanted tablets. Endocrinol 1941;28:633-642.
20
Farish E, FletcherCD,
Hart DM, et al: The effects of hormone implants on serum lipoproteins and
steroid hormones in bilaterally oophorectomised women. Acta Endocrinol
1984;106:116-120.
21
Fletcher CD, Farish E,
Hart Dm, et al: Long-term hormone implant therapy - effects on lipoproteins and
steroid levels in postmenopausal women. Acta Endocrinol 1986;111:419-423.
22
Ganger K, Fraser D,
Whitehead MI, et al: Oestrogen deficiency and oestradiol implant. Br Med J
1989;299:1279-1280.
23
Garnett TJ, Savvas, M,
Studd JWW: Reversal of bone loss with percutaneous oestrogens. In HRT and
Osteoporosis, ed by JO Drife, Studd JWW. London, Springer-Verlag, 1990,
pp295-314.
24
Garnett T, Studd J,
Watson N, et al.; A cross-sectional study of the effects of long-tem
percutaneous hormone replacement therapy in bone density. Obstet Gynecol
1991;78:1002.
25
Geist SH, Walter RI,
Salmon UJ: Prophylactic implantation of oestrogens following surgical and
radium castration. J Mount Sinai Hosp 1941;8:543-546.
26
Ginsberg J, Hardiman P,
Oestrogen deficiency and oestradiol implants. Br Med J 1989;299:1031.
27
Greenblatt RB:
Testosterone propionate pellet implantation in gynecic disorders. JAMA
1943;121:11.
28
Greenblatt RB: The use
of androgens in the menopause and other gynecic disorders. Obstet Gynecol Clin
N Am 1987;14:251-268.
29
Greenblatt RB, Asch RH,
Mahesh VB, et al: Implantation of pure crystalline estradiol for conception
control. Am J Obstet Gynecol 1977;127:520-524.
30
Greenblatt RB, Bryner
JR: Estradiol pellet implantation in the management of menopause; J Reprod Med 1977;18:307-315.
31
Greenblatt RB, Hair LZ:
Testosterone propionate pellet absorption in the female. J Clin Endocrinol
Metab 1942;2:315-317.
32
Greenblatt RB, Suran
RR: Indications for hormonal pellets in the therapy of endocrine and gynecic
disorders. Am J Obstet Gynecol 1949;57:294-301.
33
Greenblatt RB, Teran
AZ: Sexual dysfunction in women: Does Testosterone help? Contemp Obstet Gynecol
1986;28:129-135.
34
Guirgis RR; Oestradiol
implants; what dose, how often? Lancet 1987;2:856.
35
Harriet C, Anderson M,
Raju SK, et al: Oestrogen replacement after oophorectomy comparison of patches
and pellets. Br Med J 1992;305:90-91.
36
Holland EFN, Leather
AT, Studd JWW: The effect of 25 mg percutaneous estradiol implants on the bone
mass of postmenopausal women. Obstet Gynecol 1994;83:43-46.
37
Holland EFN, Studd JWW,
Mansell JP et al.: Changes in collagen composition and cross-link in bone and
skin of osteoporotic postmenopausal women treated with percutaneous estradiol
implants. Obstet Gynecol 1944;83:180-183.
38
Hunter DJS, Akande EO,
Carr P, et al: The clinical and endocrinological effect of oestradiol implants
at the time of hysterectomy and bilateral salpingo-oophorectomy. J Obstet
Gynaecol Br Com 1973;80:827-833.
39
Hunter DJS, Julier D,
Franklin M, et al:Plasma levels of oestrogen, luteinizing hormone,and follicle
stimulating hormone following castration and estradiol implant. Obstet Gynecol
1977;49:180.
40
Jarolim C,Bernard LI,
Straus Ah: Estrogen substitution therapy with pellet implantation. Am J Obstet
Gynecol 1966;170-177.
41
Kapetanakis E, Dmowski
P, Auletta F, et al: Endocrine and clinical effects of estradiol and
testosterone pellets used in long-term replacement therapy. Int Gynaecol Obstet
1982;20:387-399.
42
Kupperman HS,
Delaplaine RW, Bottomy Jr: Effective control of surgical menopause by estradiol
implantation at the time of oophorectomy and total hysterectomy. J Clin
Endocrinol Metab 1951;11:788.
43
Lipshutz A,Vargas L,:
Absorption of estradiol and its esters from subcutaneously implanted tablets in guinea pig. Pro Soc Exper
Biol Med 1941;48:464-467.
44
Lobo RA, March CM,
Goebelsmann U, et al: Subdermal estradiol pellets following hysterectomy and
oophorectomy. Am Obstet Gynecol 1980;138:714-719.
45
Loeser AA: Subcutaneous
implantation of female and male hormone in tablet form in women. Br Med J
1940;1:479.
46
Magos Al, Brincat M,
O’Dowd T, et al: Endometrial and menstrual response to subcutaneous estradiol
and testosterone implants and continuous oral progestogen therapy in
postmenopausal women. Maturitias 1985;7:297.
47
Magos Al, Brincat M,
Studd JWW: Treatment of the premenstrual syndrome by subcutaneous oestradiol
implants and oral norethisterone: placebo controlled study. Br Med J
1986;292:1629-1633.
48
Magos Al, Collins WP,
Studd JWW: Management of the premenstrual syndrome by subcutaneous implants of
oestradiol. J Psychosom Obstet Gynecol 1984;3:93-99.
49
Magos Al, Zilkha KJ,
Studd JWW: Treatment of menstrual migraine by oestradiol implants. J Neurol
Neurosurg Psychiat 1983;46:1044-1046.
50
Mishell DR: A clinical
study of estrogenic therapy with pellet implantation. Am J Obstet Gynecol
1941;41:1009-1017.
51
Montgomery JC, Appleby
L, Brincat M, et al.: Effect of estrogen and testosterone implants on
psychological disorders of the climacteria. Lancet 1987;1:297-299.
52
Nagamani M, Lin TJ,
McDonough PG, et al.: Clinical and endocrine studies in menopausal women after
estradiol pellet implantation. Obstet Gynecol 1977;50:541-547.
53
Nezhat C, Karpas AC,
Greenblatt RB, et al: Estradiol implants for conception control. Am J Obstet
Gynecol 1980;138;1151-1156.
54
Notelovitz M, Johnston
M, Smith S, et al: Metabolic and hormonal effects of 25 mg and 50 mg17-b estradiol implants in surgically menopausal women.
Obstet Gynecol 1987;70:749-754.
55
Okie V: Treatment of
menopausal by estradiol pellet implantation. NY State J Med 1949;49:1175-1176.
56
Owen EJ, Siddle NC,
McGarrigle HT, et al: 25mg oestradiol implants - the dosage of first choice for
subcutaneous oestrogen replacement therapy. Br J Obstet Gynecol
1992;99:671-675.
57
Perloff WH: Treatment
of oestrogen deficiency with estradiol pellets. J Clin Endocrinol Metab
1950;10:447-454.
58
Ralston SH, Fogelman I,
LeggateJ, et al: Effect of subdermal oestrogen and oestrogen/testosterone
implants on calcium and phosphorous homeostasis after oophorectomy. Maturitas
1984;6:341.
59
Salmon UJ, Geist SH,
Walter RI: Inhibitory effect of implanted estrogenic crystals upon
postmenopausal and castration hypophysis of women. Proced Soc Exper Biol Med
1940;43:424-426.
60
Salmon UJ, Geist SH,
Walter RI: Treatment of the menopause: Evaluation of estrogen implantation.
JAMA 1941;117:1843-1849.
61
Salmon UJ, Walter RI,
Geist SH: Prolonged therapeutic effect of subcutaneously implanted crystals of
ovarian hormone in women. Science 1939;90:162-163.
62
Savvas M, Studd JWW,
Fogelman I, et al: Skeletal effects of oral estrogen compared with subcutaneous
oestrogen and testosterone in postmenopausal women. Br Med J 1988;297:331-333.
63
Schleyer-Saunders E:
Social and gerontological problems of the menopause: hormone implants. In The
Menopausal Syndrome, ed by Greenblatt RB, Mahesh VB, McDonough PG. New York
Medcom Press 1974, pp. 88-94.
64
Sharf MS, Oettinger M,
Lanir A, et al: Lipid and lipoprotein levels following pure estradiol
implantation in post-menopausal women. Gynecol Obstet Invest 1985;19:207-212.
65
Soule SD: Treatment of
the postsurgical menopause by implantation of estradiol pellets. J Int Col Surg
1951;16:622-630.
66
Staland B: Treatment of
menopausal estrogen deficiency symptoms in hysterectomized women by means of
17-b estradiol pellet
implants. Acta Obstet Gynaecol Scand 1978;57:281-285.
67
Stanczyk FZ, Shoupe D,
Nunez V, et al: A randomized comparison of non-oral estradiol delivery in
postmenopausal women. Am J Obstet Gynecol 1988;159:1540-1546.
68
Studd JWW: Hormonal
implants in the climacteric syndrome. In The Management of the Menopause and
Postmenopause years, ed by S Campbell. London, MTP Press 1976, pp. 383-385.
69
Studd JWW, Cardozo LD,
Gibb DMF, et al: Hormone implants in women following hysterectomy and bilateral
salpingoophorectomy. In Climacteric - An Update, ed by H & B van Herendael,
FE Riphagen,et al. Boston, MTP Press, Ltd, 1983; pp149-155.
70
Studd JWW, Collins WP,
Newton JR, et al: Oestradiol and testosterone implants in the treatment of
psychosexual problems of postmenopausal women. Br J Obstet Gynecol 1977;84:314-315.
71
Studd J, Henderson A,
Garnett T, et al: Symptoms of oestrogen deficiency in women with oestradiol
implants. Br Med J 1989;299:1400-1401.
72
Studd J, Magos A:
Hormone pellet implantation for the menopause and premenstrual syndrome. Obstet
Gynecol Clin N Am 1987;14:229-249.
73
Studd JWW, Savvas M,
Fogelman I, et al: The relationship between plasma oestradiol and the increase
in bone density in postmenopausal women following subcutaneous hormone
implants. Am J Obstet Gynecol 1990;163:1474-1479.
74
Studd JWW, Savvas M,
Watson NR, et al: Monitoring oestradiol implantation. Lancet 1987;2:1404-1405.
75
Swyer, GIM: Symptoms of
oestrogen deficiency in women with oestradiol implants. Br Med J 1989;299:854.
76
Teran AZ, Gambrell RD
Jr: androgens in clinical practice. In Androgens in the Menopause, ed by L
Speroff. New York, McGraw Hill, 1988, pp14-22.
77
Thom MH, Collins WP,
Studd JWW: Hormonal profiles in postmenopausal women after therapy with
subcutaneous implants. Br J Obstet Gynaecol 1981;88:426-433.
78
Thom MH, Studd JWW: Oestrogen
and testosterone implant therapy. In Oestrogen and the Menopause, ed Whitehead
MJ, Campbell S, Queensboro, Kent, Abbott Laboratories, Ltd, 1978, pp 85-88.
79
Thom MH, Studd JWW:
Procedures in practice: Hormone Implantation, Br Med J 1980;1:848-850.
80
Tobias JH, Chambers TJ:
Symptoms of oestrogen deficiency in women with oestradiol implants. Br Med J
1989;299:854.
81
Twombly GH, Millen Rs:
The implantation of solid pellets of estrogens in the treatment of menopausal
symptoms. Surg Gynecol Obstet 1941;72:605-610.
82
Walter RI, Geist SH,
Salmon UJ: Absorption rates and biologic effects of pellets of a-estradiol and
a-estradiol benzoate in women. Proc Soc Exper Biol Med
1940;44:314-318.
83
Wardle P, Fox R:
Symptoms of oestrogen deficiency in women with oestradiol implants Br Med J
1989;299.
84 Watson NR, Studd JWW, Savvas M, et al.: The long term effects of estradiol implant therapy for treatment of pre-menopausal syndrome. Gynecol Endocrinol 1990;4:99-107.